000 01527 a2200433 4500
005 20250516003808.0
264 0 _c20110427
008 201104s 0 0 eng d
022 _a1873-5592
024 7 _a10.2174/138945011794182719
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDas, R A
245 0 0 _aCombined treatment modalities for age related macular degeneration.
_h[electronic resource]
260 _bCurrent drug targets
_cFeb 2011
300 _a182-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBlindness
_xetiology
650 0 4 _aChoroidal Neovascularization
_xdrug therapy
650 0 4 _aCombined Modality Therapy
_xtrends
650 0 4 _aDexamethasone
_xtherapeutic use
650 0 4 _aDisease Progression
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMacular Degeneration
_xdrug therapy
650 0 4 _aPhotochemotherapy
650 0 4 _aPhotosensitizing Agents
_xpharmacology
650 0 4 _aPorphyrins
_xpharmacology
650 0 4 _aVascular Endothelial Growth Factors
_xantagonists & inhibitors
650 0 4 _aVerteporfin
650 0 4 _aWet Macular Degeneration
_xdrug therapy
700 1 _aRomano, A
700 1 _aChiosi, F
700 1 _aMenzione, M
700 1 _aRinaldi, M
773 0 _tCurrent drug targets
_gvol. 12
_gno. 2
_gp. 182-9
856 4 0 _uhttps://doi.org/10.2174/138945011794182719
_zAvailable from publisher's website
999 _c20215349
_d20215349